BRIEF published on 04/24/2024 at 14:05, 1 year 7 months ago PEG Companies Appoints Garett Bjorkman as Co-Chief Executive Officer Real Estate Investment Asset Management Garett Bjorkman Co-CEO Appointment PEG Companies
PRESS RELEASE published on 04/24/2024 at 14:00, 1 year 7 months ago PEG Companies Appoints Garett Bjorkman as Co-Chief Executive Officer PEG Companies appoints Garett Bjorkman as Co-CEO to enhance asset management capabilities and drive growth. Bjorkman brings extensive experience from CIM Group Asset Management Commercial Real Estate Co-CEO Garett Bjorkman PEG Companies
PRESS RELEASE published on 08/28/2023 at 16:00, 2 years 3 months ago PEG Companies Recognized Among Utah's Elite 'Fast50' Companies
PRESS RELEASE published on 03/27/2023 at 15:00, 2 years 8 months ago Highly Anticipated Courtyard by Marriott Nanaimo Hotel Opens for Business
Published on 12/05/2025 at 02:35, 2 hours 52 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 27 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 22 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 27 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 56 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 36 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 1 minute ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 12 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 16 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 27 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 42 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 43 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 26 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
